Speech disorders in Parkinson's disease and the effects of pharmacological, surgical and speech treatment with emphasis on Lee Silverman voice treatment (LSVT®)

Handbook of Clinical Neurology

Volumn 83, Issue , 2007, Pages 385-399

  Ramig, Lorraine Olson ^a,b,c   Fox, Cynthia ^c   Sapir, Shimon ^d  

^a UNIVERSITY OF COLORADO   (United States)

^b Columbia University ^*  (United States)

^c University of Arizona   (United States)

^d UNIVERSITY OF HAIFA   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649319286     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)83017-X     Document Type: Review

References (163)

1. Ackermann H., and Ziegler W. Articulatory deficits in parkinsonian dysarthria. J Neurol Neurosurg Psychiatry 54 (1991) 1093-1098
2. Ackermann H., Konczak J., and Hertrich I. The temporal control of repetitive articulatory movements in Parkinson's disease. Brain Lang 56 (1997) 312-319
3. Adams S.G. Hypokinetic dysarthria in Parkinson's disease. In: McNeil M.R. (Ed). Clinical Management of Sensorimotor Speech Disorders (1997) Thieme, New York
4. Albin R.L., Young A.B., and Penny J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci 12 (1989) 366-375
5. Allan C.M. Treatment of non-fluent speech resulting from neurological disease: treatment of dysarthria. Br J Disord Commun 5 (1970) 3-5
6. Anon. Speech therapy in Parkinson's disease. Mov. Disord 17 Suppl 4 (2002) S163-S166
7. Aronson A.E. Clinical Voice Disorders (1990), Thieme-Stratton, New York
8. Baker K., Ramig L.O., Johnson A., et al. Preliminary speech and voice analysis following fetal dopamine transplants in 5 people with Parkinson disease. J Speech Hear Res 40 3 (1997) 615-626
9. Baker K., Ramig L.O., Luschei E., et al. Thyroarytenoid muscle activity associated with hypophonia in Parkinson disease and aging. Neurology 51 6 (1998) 1592-1598
10. Barbeau A., Sourkes T.L., and Murphy C.F. Les catecholamines de la maladie de Parkinson's. In: Ajuriaguerra J. (Ed). Monoamines et Systeme Nerveux Central (1962), George, Geneve
11. Barker L.J. Computer-assisted vocabulary acquisition: the CSLU vocabulary tutor in oral deaf education. J Deaf Stud Deaf Edu 8 2 (2003) 187-198
12. Baumgartner C., Sapir S., and Ramig L.O. Voice quality changes following phonatory-respiratory effort treatment (LSVT®) versus respiratory effort treatment for people with Parkinson disease. J Voice 14 1 (2001) 105-114
13. Berardelli A., Dick J.P., Rothwell J.C., et al. Scaling of the size of the first agonist EMG burst during rapid wrist movements in people with Parkinson's disease. J Neurol Neurosurg Psychiatry 49 11 (1986) 1273-1279
14. In: Beukelman D.R. (Ed). Recent Advances in Clinical Dysarthria (1989), College-Hill Press, Boston
15. Brown A.B., McCartney N., and Sale D.G. Positive adaptations to weight-lifting training in the elderly. J Appl Physiol 69 5 (1990) 1725-1733
16. Caligiuri M.P. Labial kinematics during speech in people with parkinsonian rigidity. Brain 110 (1987) 1033-1044
17. Caligiuri M.P. The influence of speaking rate on articulatory hypokinesia in Parkinsonian dysarthria. Brain Lang 36 (1989) 493-502
18. Caligiuri M.P. Short-term fluctuations in orofacial motor control in Parkinson's disease. In: Yorkson K.M., and Beukelman D.R. (Eds). Recent Advances in Clinical Dysarthria (1989), College Hill, Boston
19. Caligiuri M.P., and Abbs J.H. Response properties of the perioral reflex in Parkinson's disease. Exp Neurol 98 (1987) 563-572
20. Canter G.J. Speech characteristics of people with Parkinson's disease: I. Intensity, pitch and duration. J Speech Hear Disord 28 (1963) 221-229
21. Canter G.J. Speech characteristics of people with Parkinson's disease: III. Articulation, diadochokinesis and overall speech adequacy. J Speech Hear Disord 30 (1965) 217-224
22. Canter G.J. Speech characteristics of people with Parkinson's disease: II. Physiological support for speech. J Speech Hear Disord 30 (1965) 44-49
23. Cole R., Carmell T., Conners P., et al. Intelligent animated agents for interactive language training. Proceedings of STiLL: ESCA Workshop On Speech Technology in Language Training. Stockholm, Sweden (1998)
24. Cole R., Massaro D.W., deVilliers J., et al. New tools for interactive speech and language training: using animated conversational agents in the classrooms of profoundly deaf children. Proceedings of ESCA/SOCRATES Workshop on Method and Tool Innovations for Speech Science Education. London, UK (1999)
25. Cole R., VanVuuren S., Pellom B., et al. Perceptive animated interfaces: first steps toward a new paradigm for human-computer interaction. Proceedings of The IEEE: Special Issue on Human Computer Multimodal Interface 91 9 (2003) 1391-1405
26. COLIT03, The Web site:. http://cslr.Colorado.edu/beginweb/reading/reading.html provides an overview of reading tutors that use animated agent technologies as part of the Colorado Literacy Tutor project. (Also please see reprint by Cole et al., included with proposal.)
27. Conner N.P., and Abbs J.H. Task-dependent variations in parkinsonian motor impairments. Brain 114 (1991) 321-332
28. Connor N.P., Abbs J.H., Cole K.J., et al. Parkinsonian deficits in serial multiarticulate movements for speech. Brain 112 (1989) 997-1009
29. Countryman S., and Ramig L.O. Effects of intensive voice therapy on speech deficits associated with bilateral thalamotomy in Parkinson's disease: a case study. J Med Speech Lang Pathol 4 (1993) 233-249
30. Cramer W. De spaak bij patienten met Parkinsonisme. Logop Phoniatr 22 (1940) 17-23
31. Critchley E. Speech disorders of Parkinsonism: a review. J Neurol Neurosurg Psychiatry 44 (1981) 751-758
32. Darley F.L., Aronson A.E., and Brown J.R. Clusters of deviant speech dimensions in the dysarthrias. J Speech Hear Res 12 (1969) 462-469
33. Darley F.L., Aronson A.E., and Brown J.R. Differential diagnostic patterns of dysarthria. J Speech Hear Res 12 (1969) 246-269
34. Darley F.L., Aronson A.E., and Brown J.R. Motor Speech Disorders (1975), WB Saunders, Philadelphia
35. De la Torre R., Mier M., and Boshes B. Evaluation of respiratory function: preliminary observations. Q Bull Northwest Univ Med Sch 34 (1960) 332-336
36. Deane K., Whurr R., Playford E.D., et al. Speech and language therapy for dysarthria in Parkinson's disease: a comparison of techniques (Cochrane Review). the Cochrane Library, Issue 2 (2004), John Wiley & Sons Ltd, Chichester, UK
37. Deane K., Whurr R., Playford E.D., et al. Speech and language therapy versus placebo or no intervention for dysarthria in Parkinson's disease (Cochrane Review). the Cochrane Library, Issue 2 (2004), John Wiley & Sons Ltd, Chichester, UK
38. Demirci M., Grill S., McShane L., et al. Impairment of kinesthesia in Parkinson's disease. Neurology 45 (1995) A218
39. Demirci M., Grill S., McShane L., et al. A mismatch between kinesthetic and visual perception in Parkinson's disease. Ann Neurol 41 (1997) 781-788
40. Diamond S.G., Schneider J.S., and Markham C.H. Oral sensorimotor defects in people with Parkinson's disease. Adv Neurol 45 (1987) 335-338
41. Downie A.W., Low J.M., and Lindsay D.D. Speech disorders in Parkinsonism: usefulness of delayed auditory feedback in selected cases. Br J Disord Commun 16 (1981) 135-139
42. Dromey C. Articulatory kinematics in people with Parkinson's disease using different speech treatment approaches. J Med Speech Lang Pathol 8 (2001) 155-161
43. Dromey C., Ramig L.O., and Johnson A. Phonatory and articulatory changes associated with increased vocal intensity in Parkinson disease: a case study. J Speech Hear Res 38 (1995) 751-763
44. El Sharkawi A., Ramig L.O., Logemann J.A., et al. Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT®): a pilot study. J Neurol Neurosurg Psychiatry 71 (2002) 31-36
45. Estenne M., Hubert M., and Troyer A.D. Respiratory-muscle involvement in Parkinson's disease. N Engl J Med 311 23 (1984) 1516-1517
46. Evidence Based Medical Review for the Treatments of Parkinson's Disease (Evidence Review Committee). Speech therapy in Parkinson's disease. Mov Disord 17 Suppl 4 (2002) S163-S166
47. Farley B., and Koshland G. Efficacy of a large-amplitude exercise approach for patients with Parkinson's disease-bradykinesia to balance. Poster Presented at the 9th International Congress of Parkinson's Disease and Movement Disorders. New Orleans, LA (2005)
48. Farley B., Koshland C.F., and Prior M.M. Learning big decreases bradykinesia in the upper and lower limbs in people with Parkinson's disease. A Poster Presented at the Annual Society for Neuroscience Meeting. San Diego, CA (2004)
49. Fisher B., Petzinger G., Nixon K., et al. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia. J Neurosci Res 77 (2004) 378-390
50. Forrest K., Weismer G., and Turner G. Kinematic, acoustic and perceptual analysis of connected speech produced by Parkinsonian and normal geriatric adults. J Acoust Soc Am 85 (1989) 2608-2622
51. Fox C., and Ramig L.O. Vocal sound pressure level and self-perception of speech and voice in men and women with idiopathic Parkinson disease. Am J Speech Lang Pathol (1997) 229-242
52. Fox C., Farley B., Ramig L.O., et al. An integrated rehabilitation approach for Parkinson disease: learning big and loud. Poster Presented at the 9th International Congress of Parkinson's Disease and Movement Disorders. New Orleans LA (2005)
53. Fox C.M., and Farley B. Learning big and loud: an integrated rehabilitation approach to Parkinson's disease. Soc Neurosci (2004) Abstr.#874.10)
54. Fox C.M., Morrison C.E., Ramig L.O., et al. Current perspectives on the lee silverman voice treatment (LSVT) for people with idiopathic Parkinson's disease. Am J Speech Lang Pathol 11 (2002) 111-123
55. Fraile V., and Cohen H. Prosody in Parkinson's disease: relations between duration, amplitude and fundamental frequency range. Paper Presented at the International Neuropsychological Society 23rd Annual Meeting. Seattle, WA (1995)
56. Frontera W.R., Meredith C.N., O'Reilly K.P., et al. Strength conditioning in older men: skeletal muscle hypertrophy and improved function. J Appl Physiol 64 3 (1988) 1038-1044
57. Garren K., Brosovic G., Abaza M., et al. Voice therapy and Parkinson disease: measures of vocal fold adduction. Paper Presented at the Voice Symposium. Philadelphia, PA, June (2000)
58. Gath I., and Yair E. Analysis of vocal tract parameters in parkinsonian speech. J Acoust Soc Am 84 (1988) 1628-1634
59. Ghika J., Ghika-Schmid F., Fankhauser H., et al. Bilateral contemporaneous posteroventral pallidotomy for the treatment of Parkinson's disease: neuropsychological and neurological side effects. Report of four cases and review of the literature. J Neurosurg 91 2 (1999) 313-321
60. Goetz C. (2003) Personal Communication
61. Graber S., Hertrich I., Daum I., et al. Speech perception deficits in Parkinson's disease: underestimation of time intervals compromises identification of durational phonetic contrasts. Brain Lang 82 (2002) 65-74
62. Greene H.C.L. The Voice and Its Disorders (1980), Pitman Medical, London
63. Halpern A., Matos C., Ramig L.O., et al. LSVTC-a PDA supported speech treatment for Parkinson's disease. A Poster Presented to the Annual American Speech- Language-Hearing Association Meeting. Philadelphia, PA (2004)
64. Halpern A., Matos C., Ramig L.O., et al. LSVTC-A PDA supported speech treatment for Parkinson's disease. Presented at the 9th International Congress of Parkinson's Disease and Movement Disorders. New Orleans, LA (2005)
65. Hammen V.L., Yorkston K.M., and Beukelman DR. Pausal and speech duration characteristics as a function of speaking rate in normal and Parkinsonian dysarthric people. In: Yorkston K.M., and Beukelman D.R. (Eds). Recent Advances in Clinical Dysarthria (1989), College-Hill Press, Boston
66. Hansen D.G., Gerratt B.R., and Ward P.H. Cinegraphic observations of laryngeal function in Parkinson's disease. Laryngoscope 94 (1984) 348-353
67. Hanson W.R., and Metter E.J. Daf speech rate modification in Parkinson's disease: a report of two cases. In: Berry W.R. (Ed). Clinical Dysarthria (1983), College-Hill Press, San Diego
68. Hartelius L., and Svensson P. Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: a survey. Folia Phoniatr Logop 46 (1994) 9-17
69. Helm N. Management of palilalia with a pacing board. J Speech Hear Disord 44 (1979) 350-353
70. Hill A.N., Jankovic J., Vuong K.D., et al. Treatment of hypophonia with collagen vocal cord augmentation for people with parkinsonism. Mov Disord 18 10 (2003) 1190-1192
71. Hirose H. Pathophysiology of motor speech disorders (dysarthria). Folia Phoniatr (Basel) 38 (1986) 61-88
72. Hirose H., Kiritan S., Ushijima T., et al. Patterns of dysarthric movements in people with Parkinsonism. Folia Phoniatr 33 4 (1981) 204-215
73. Ho A.K., Iansek R., Marigliani C., et al. Speech impairment in a large sample of people with Parkinson's disease. Behav Neurol 11 (1998) 131-137
74. Ho A.K., Bradshaw J.L., Iansek R., et al. Speech volume regulation in Parkinson's disease: effects of implicit cues and explicit instructions. Neuropsychologia 37 (1999) 1453-1460
75. Ho A.K., Iansek R., and Bradshaw J.L. Regulations of parkinsonian speech volume: the effect of interlocuter distance. J Neurol Neurosurg Psychiatry 67 2 (1999) 199-202
76. Ho A.K., Bradshaw J.L., and Iansek T. Volume perception in parkinsonian speech. Mov Disord 15 (2000) 1125-1131
77. Ho A.K., Iansek R., and Bradshaw J.L. Motor instability in parkinsonian speech intensity. Neuropsychiatry Neuropsychol Behav Neurol 14 (2001) 109-116
78. Hoodin R.B., and Gilbert H.R. Nasal airflows in parkinsonian speakers. J Commun Disord 22 (1989) 169-180
79. Hoodin R.B., and Gilbert H.R. Parkinsonian dysarthria: an aerodynamic and perceptual description of velopharyngeal closure for speech. Folia Phoniatr 41 (1989) 249-258
80. Houde J., Nagarajan S., Heinks T., et al. The effects of voice therapy on feedback control in parkinsonian speech. Mov Disord 19 Suppl 9 (2004) S403
81. Hunker C.J., and Abbs J.H. Physiological analyses of Parkinsonian tremors in the orofacial system. In: McNeil M.R., Rosenbek J.C., and Aronson A.E. (Eds). The Dysarthrias: Physiology, Acoustics, Perception, Management (1984), College-Hill Press, San Diego
82. Jobst E.E., Melnick M.E., Byl N.N., et al. Sensory perception in Parkinson's disease. Arch Neurol 54 (1997) 450-454
83. Johnson J., and Pring T. Speech therapy and Parkinson's disease: a review and further data. Br J Disord Commun 125 (1990) 183-194
84. Kleim J., and Jones T. Neurorehabilitation Workgroup: Innovation and Evolution Workshop. Gainesville, FL April 10-12, 2005 (2005)
85. Kleim J., Jones T., and Schallert T. Motor enrichment and the induction of plasticity before or after brain injury. Neurochem Res 11 (2003) 1757-1769
86. Klockgether T., Borutta M., Rapp H., et al. A defect of kinesthesia in Parkinson's disease. Brain 120 (1997) 460-465
87. Koller W.C. Sensory symptoms in PD. Neurology 34 (1984) 957-959
88. Kompoliti K., Wang Q.E., Goetz C.G., et al. Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology 54 (2000) 458-462
89. Krack P., Batir A., Van Biercom N., et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 345 20 (2003) 1925-1934
90. Larson K., Ramig L.O., and Scherer R.C. Acoustic and glottographic voice analysis during drug-related fluctuations in Parkinson's disease. J Med Speech Lang Pathol 2 (1994) 211-226
91. Laszewski Z. Role of the department of rehabilitation in preoperative evaluation of Parkinsonian people. J Am Geriatr Soc 4 (1956) 1280-1284
92. Leanderson R., Meyerson B.A., and Persson A. Effect of L-dopa on speech in Parkinsonism. An EMG study of labial articulatory function. J Neurol Neurosurg Psychiatry 43 (1971) 679-681
93. Leanderson R., Meyerson B.A., and Persson A. Lip muscle function in Parkinsonian dysarthria. Acta Otolaryngol 74 (1972) 350-357
94. Liepert J., Miltner W.H., Bouder H., et al. Motor cortex plasticity during constraint-induced movement therapy in stroke patients. Neurosci Lett 250 (1998) 5-8
95. Liotti M., Vogel D., Ramig L.O., et al. Modifications of brain function following LSVT®: a PET study. Paper Presented at the American Speech-Language Hearing Association Annual Meeting. San Antonio, TX (1998)
96. Liotti M., Ramig L.O., Vogel D., et al. Hypophonia in Parkinson's disease: neural correlates of voice treatment revealed by PET. Neurology 60 (2003) 432-440
97. LLOUD03 website:. http://cslr.Colorado.edu/beingweb/animated_speech_therapist.html provides short videos comparing the LSVT virtual therapist to a human therapist
98. Logemann J.A., Boshes B., and Fisher H. The steps in the degeneration of speech and voice control in Parkinson's disease. In: Siegfried J. (Ed). Parkinson's Diseases: Rigidity, Akinesia, Behavior. Hans Huber, Vienna (1973)
99. Logemann J., Fisher H., Boshes B., et al. Frequency and concurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson people. J Speech Hear Disord 43 (1978) 47-57
100. Ludlow C.L., and Bassich C.J. Relationships between perceptual ratings and acoustic measures of hypokinetic speech. In: McNeil M.R., Rosenbek J.C., and Aronson A.E. (Eds). Dysarthria of Speech: Physiology-Acoustics-Linguistics-Management (1983), College-Hill Press, San Diego
101. Ludlow C.L., and Bassich C.J. Relationships between perceptual ratings and acoustic measures of hypokinetic speech. In: McNeil M.R., Rosenbek J.C., and Aronson A.E. (Eds). The Dysarthrias: Physiology, Acoustics, Perception, Management (1984), College-Hill, San Diego
102. Luschei E.S., Ramig L.O., Baker K.L., et al. Discharge characteristics of laryngeal single motor units during phonation in young and older adults and in persons with Parkinson disease. J Neurophysiol 81 5 (1999) 2131-2139
103. Marquardt T.P. Characteristics of Speech in Parkinson's disease: Electromyographic, Structural Movement and Aerodynamic Measurements (1973), University of Washington, Seattle
104. Marsden C.D. The mysterious motor function of the basal ganglia: the Robert Wartenberg lecture. Neurology 32 5 (1982) 514-539
105. Mawdsley C. Speech and levodopa. Adv Neurol 3 (1973) 33-47
106. Mawdsley C., and Gamsu C.V. Periodicity of speech in Parkinsonism. Nature 231 (1971) 315-316
107. Metter E.J., and Hanson W.R. Clinical and acoustical variability in hypokinetic dysarthria. J Commun Disord 19 (1986) 347-366
108. Moore C.A., and Scudder R.R. Coordination of jaw muscle activity in Parkinsonian movement: description and response to traditional treatment. In: Yorkston K.M., and Beukelman D.R. (Eds). Recent Advances in Clinical Dysarthria (1989), College-Hill Press, Boston MA
109. Mueller P.B. Parkinson's disease: motor-speech behavior in a selected group of people. Folia Phoniatr 23 (1971) 333-346
110. Murdoch B.E., Chenery H.J., Bowler S., et al. Respiratory function in Parkinson's people exhibiting a perceptible speech deficit: a kinematic and spirometric analysis. J Speech Hear Disord 54 (1989) 610-626
111. Nakano K.K., Zubick H., and Tyler H.R. Speech defects of Parkinsonian people: effects of levodopa therapy on speech intelligibility. Neurology 23 8 (1973) 865-870
112. Narayana S., Vogel D., Brown S., et al. Mechanism of action of voice therapy in Parkinson's hypophonia-A PET study. A Poster Presented at the 11th Annual Meeting of the Organization for Human Brain Mapping. Toronto, Ontario, Canada (2005)
113. Netsell R., Daniel B., and Celesia G.G. Acceleration and weakness in Parkinsonian dysarthria. J Speech Hear Disord 40 (1975) 170-178
114. Oxtoby M. Parkinson's Disease People and Their Social Needs (1982), Parkinson's Disease Society, London
115. Penny J.B., and Young A.B. Speculations on the functional anatomy of basal ganglia disorders. Annu Rev Neurosci 6 (1983) 73-94
116. Perez K., Ramig L.O., Smith M., et al. The Parkinson larynx: tremor and videostroboscopic findings. J Voice 10 (1996) 354-361
117. Pinto S., Ozsancak C., Tripoliti E., et al. Treatments for dysarthira in Parkinson's disease. Lancet 3 (2004) 547-556
118. Pitcairn T., Clemie S., Gray J., et al. Non-verbal cues in the self presentation of parkinsonian people. Br J Clin Psychology 29 (1990) 177-184
119. Pitcairn T., Clemie S., Gray J., et al. Impressions of parkinsonian people from their recorded voices. Br J Disord Commun 25 (1990) 85-92
120. Ramig L.O., and Dromey C. Aerodynamic mechanisms underlying treatment-related changes in SPL in people with Parkinson disease. J Speech Hear Res 39 (1996) 798-807
121. Ramig L.O., Countryman S., Thompson L., et al. Comparison of two forms of intensive speech treatment for Parkinson disease. J Speech Hear Res 38 (1995) 1232-1251
122. Ramig L.O., Pawlas A., and Countryman S. The Lee Silverman Voice Treatment (LSVT): A Practical Guide to Treating the Voice and Speech Disorders in Parkinson Disease (1995), National Center for Voice and Speech, Iowa City, IA
123. Ramig L.O., Countryman S., O'Brien C., et al. Intensive speech treatment for people with Parkinson's disease: short and long term comparison of two techniques. Neurology 47 (1996) 1496-1504
124. Ramig L.O., Sapir S., and Countryman S. Intensive voice treatment (LSVT®) for people with Parkinson's disease: a 2 year follow-up. J Neurol Neurosurg Psychiatry 71 (2001) 493-498
125. Ramig L.O., Sapir S., Fox C., et al. Changes in vocal intensity following intensive voice treatment (LSVT®) in people with Parkinson disease: a comparison with untreated people and with normal age-matched controls. Mov Disord 16 (2001) 79-83
126. Rickards C., and Cody F.W. Proprioceptive control of wrist movements in Parkinson's disease. Brain 120 (1997) 977-990
127. Rigrodsky S., and Morrison E.B. Speech changes in Parkinsonism during L-dopa therapy: preliminary findings. J Am Geriatr Soc 18 (1970) 142-151
128. Robertson S.J., and Thomson F. Speech therapy in Parkinson's disease: a study of the efficacy and long term effects of intensive treatment. Br J Disord Commun 18 3 (1984) 213-224
129. Rosenfeld D. Parmacologic approaches to speech motor disorders. In: Vogel D., and Cannito M. (Eds). Treating Disordered Speech Motor Control (1991), Pro-ed, Austin 111-152
130. Sapir S., Pawlas A.A., Ramig L.O., et al. Voice and speech abnormalities in Parkinson disease: relation to severity of motor impairment, duration of disease, medication, depression, gender, and age. J Med Speech Lang Pathol 9 4 (2001) 213-226
131. Sapir S., Ramig L., Hoyt P., et al. Phonatory-Respiratory effort (LSVT®) vs. respiratory effort treatment for hypokinetic dysarthria: comparing speech loudness and quality before and 12 months after treatment. Folia Phoniatr 54 54 (2002) 296-303
132. Sarno M.T. Speech impairment in Parkinson's disease. Arch Phys Med Rehabil 49 5 (1968) 269-275
133. Schiffman P.L. A "saw-tooth" pattern in Parkinson's disease. Chest 87 (1985) 24-126
134. Schmidt R.A., and Lee T.D. Motor Control and Learning: A Behavioral Emphasis (1999), Human Kinetic Publishers, Champaign, IL
135. Schneider J.S., and Lidsky T.I. Basal Ganglia and Behavior: Sensory Aspects of Motor Functioning (1987), Hans Huber, Toronto
136. Schneider J.S., Diamond S.G., and Markham C.H. Deficits in orofacial sensorimotor function in Parkinson's disease. Ann Neurol 19 (1986) 275-282
137. Schultz G.M., and Grant M.K. Effects of speech therapy and pharmacologic and surgical treatments on voice and speech in Parkinson's disease: a review of the literature. J Commun Disord 33 (2000) 59-88
138. Schultz G.M., Peterson T., Sapienza C.M., et al. Voice and speech characteristics of persons with Parkinson's disease pre- and post-pallidotomy surgery: preliminary findings. J Speech Hear Res 42 (1999) 1176-1194
139. Scott S., and Caird F.L. Speech therapy for people with Parkinson's disease. Br Med J 283 (1981) 1088
140. Scott S., and Caird F.L. Speech therapy for Parkinson's disease. J Neurol Neurosurg Psychiatry 46 (1983) 140-144
141. Smith M., Ramig L.O., and Dromey C. Intensive voice treatment in Parkinson's disese: laryngostroboscopic findings. J Voice 9 (1995) 453-459
142. Solomon N.P., and Hixon T.J. Speech breathing in Parkinson's disease. J Speech Hear Res 36 (1993) 294-310
143. Solomon N.P., Robin D.A., Lorell D.M., et al. Tongue function testing in Parkinson's disease: indicators of fatigue. In: Till J.A., Yorkston K.M., and Beukelman R. (Eds). Motor Speech Disorders: Advances in Assessment and Treatment (1994), Paul H. Brooks, Baltimore 147-160
144. Spielman J., Borod J., and Ramig L. Effects of intensive voice treatment (LSVT) on facial expressiveness in Parkinson's disease: preliminary data. Cogn Behav Neurol 16 3 (2003) 177-188
145. Stelmach G.E. Basal ganglia impairment and force control. In: Requin J., and Stelmach G.E. (Eds). Tutorial in Motor Neuroscience (1991), Kluwer Academic Publishers, The Netherlands
146. Stone P. Revolutionizing language instruction in oral deaf education. Proceedings of the International Conference of Phonetic Sciences. San Francisco, CA (1999)
147. Taub E. Harnessing brain plasticity through behavioral techniques to produce new treatments in neurorehabilitation. Am Psychol 59 8 (2004) 692-704
148. Tillerson J.L., Cohen A.D., Philhower J., et al. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci 21 12 (2001) 4427-4435
149. Tillerson J.L., Caudle W.M., Reveron M.E., et al. Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease. Neuroscience 119 3 (2003) 899-911
150. Uziel A., Bohe M., Cadilhac J., et al. Les troubles de la voix et de la parole dans les syndromes Parkinson'siens. Folia Phoniatr 27 3 (1975) 166-176
151. Verdolini K. Principles of skill acquisition. Implication for voice training. In: Hampton M., and Acker B. (Eds). The Vocal Vision. View on Voice (1997), Applause, New York 65-80
152. Vincken W.G., Gauthier S.G., Dollfuss R.E., et al. Involvement of upper-airway muscles in extrapyramidal disorders, a cause of airflow limitation. N Engl J Med 7 311 (1984) 438-442
153. Wang E., Kompoliti K., Jiang J., et al. An instrumental analysis of laryngeal responses to apomorphine stimulation in Parkinson disease. J Med Speech Lang Pathol 8 (2002) 175-186
154. Wang E., Verhagen Metman L., Bakay R., et al. The effect of unilateral electrostimulation of the subthalamic nucleus on respiratory/phonatory subsystems of speech production in Parkinson's disease: a preliminary report. Clin Linguist Phon 17 4-5 (2003) 283-289
155. Weiner W.J., and Lang A.E. Movement Disorders A Comprehensive Survey (1989), Futura, Mount Kisko, New York
156. Weiner W.J., and Singer C. Parkinson's Disease and Nonpharmacologic Treatment Programs. J Am Geriatr Soc 37 (1989) 359-363
157. Weismer G. Articulatory characteristics of Parkinsonian dysarthria: segmental and phrase-level timing, spirantization and glottal-supraglottal coordination. In: McNeil M.R., Rosenbeck J., and Aronson A.E. (Eds). The Dysarthrias: Physiology, Acoustics, Perception and Management (1984), College Hill Press, San Diego
158. Wolfe V.I., Garvin J.S., Bacon M., et al. Speech changes in Parkinson's disease during treatment with L-dopa. J Commun Disord 8 3 (1975) 271-279
159. Yaryura-Tobias J.A., Diamond B., and Merlis S. Verbal communication with L-dopa treatment. Nature 234 (1971) 224-225
160. Yorkston K.M. Treatment efficacy: dysarthria. J Speech Hear Res 39 (1996) S46-S57
161. Yorkston K.M., Miller R.M., and Strand E.A. Management of Speech and Swallowing in Degenerative Diseases. Communication Skill Builders, publisher (1997)
162. Yorkston K.M., Spencer K.A., and Duffy J.R. Behavioral management of respiratory/phonatory dysfunction from dysarthria: a systematic review of the evidence. J Med Speech Lang Pathol 11 (2003) xiii-xxxviii
163. Liotti M., Vogel D., Sapir S., et al. Abnormal auditory gating in Parkinson's disease before and after LSVT. Paper presented at the Annual Meeting of the American Speech, Language and Hearing Association. Washington, DC, November (2000)